Global Radiofrequency Ablation Market 2017-2021

SKU ID :TNV-10580513 | Published Date: 12-Apr-2017 | No. of pages: 70
Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Key market highlights PART 05: Market landscape • Market overview • Five forces analysis PART 06: Market segmentation by product • Global radiofrequency ablation consumables and accessories market • Global radiofrequency ablation systems market • Global radiofrequency ablation catheters market PART 07: Market segmentation by application • Oncology • Cardiovascular • Pain management • Cosmetology • Gynecology PART 08: Market segmentation by end-user • Hospitals • ASCs • Physicians’ offices PART 09: Geographical segmentation • Radiofrequency ablation market in Americas • Radiofrequency ablation market in EMEA • Radiofrequency ablation market in APAC PART 10: Decision framework PART 11: Drivers and challenges • Market drivers • Impact of drivers on key customer segments • Market challenges • Impact of challenges on key customer segments PART 12: Market trends • New product launches coupled with R&D activities • Increasing M&A • Emergence of robotic navigation technologies • Adoption of radiofrequency ablation in emerging economies PART 13: Vendor landscape • Competitive scenario PART 14: Key vendor analysis • AngioDynamics • Boston Scientific • Medtronic • St. Jude Medical • Stryker • Other prominent vendors PART 15: Appendix • List of abbreviations List of Exhibits Exhibit 01: Global radiofrequency ablation market 2016-2021 ($ millions) Exhibit 02: Five forces analysis Exhibit 03: Global radiofrequency ablation market by product type 2016-2021 ($ millions) Exhibit 04: Global radiofrequency ablation market by product type 2016-2021 Exhibit 05: Global radiofrequency ablation consumables and accessories market 2016-2021 ($ millions) Exhibit 06: Global radiofrequency ablation systems market 2016-2021 ($ millions) Exhibit 07: Common ablation catheters used during radiofrequency ablation procedure Exhibit 08: Benefits of advanced radiofrequency ablation catheters Exhibit 09: Global radiofrequency ablation catheters market 2016-2021 ($ millions) Exhibit 10: Global radiofrequency ablation market by application 2016 Exhibit 11: Global radiofrequency ablation market by end-user 2016 Exhibit 12: Global radiofrequency ablation market by geography 2016-2021 Exhibit 13: Global radiofrequency ablation market by geography 2016: Lifecycle analysis Exhibit 14: Global radiofrequency ablation market analysis by geography 2016 Exhibit 15: Global radiofrequency ablation market by geography 2016-2021 ($ millions) Exhibit 16: Global radiofrequency ablation market by geography 2016-2021 Exhibit 17: Radiofrequency ablation market in Americas 2016-2021 ($ millions) Exhibit 18: Radiofrequency ablation market in EMEA 2016-2021 ($ millions) Exhibit 19: Radiofrequency ablation market in APAC 2016-2021 ($ millions) Exhibit 20: Cancer types worldwide 2012 Exhibit 21: Impact of drivers Exhibit 22: Product recalls in radiofrequency ablation market 2015-2016 Exhibit 23: Impact of challenges Exhibit 24: New product launches 2015-2016 Exhibit 25: Ongoing clinical trials for radiofrequency ablation Exhibit 26: Key M&A 2016–2017 Exhibit 27: Competitive structure of global radiofrequency ablation market Exhibit 28: Competitive parameters in global radiofrequency ablation market Exhibit 29: AngioDynamics: Strength assessment Exhibit 30: AngioDynamics: Strategy assessment Exhibit 31: AngioDynamics: Opportunity assessment Exhibit 32: Boston Scientific: Strength assessment Exhibit 33: Boston Scientific strategy assessment Exhibit 34: Boston Scientific: Opportunity assessment Exhibit 35: Medtronic: Strength assessment Exhibit 36: Medtronic; Strategy assessment Exhibit 37: Medtronic; Opportunity assessment Exhibit 38: St. Jude Medical: Strength assessment Exhibit 39: St. Jude Medical: Strategy assessment Exhibit 40: St. Jude Medical: Opportunity assessment Exhibit 41: Stryker: Strength assessment Exhibit 42: Stryker: Strategy assessment Exhibit 43: Stryker: Opportunity assessment
AngioDynamics, Boston Scientific, Medtronic, St. Jude Medical, Stryker, Accuray, Advanced Cardiac Therapeutics, APT Medical, Arthrex, AtriCure, Biosense Webster, BIOTRONIK, Bovie Medical, CardioFocus, CONMED, DVx, Hansen Medical, Halyard Health, Imricor Medical Systems, Japan Lifeline, Merit Medical Systems, MicroPort Scientific, Osypka Medical, PLC Medical Systems, RF Medical, Smith & Nephew, Spacelabs Healthcare, Spectranetics, Theraclion, and Total Vein Systems.
  • PRICE
  • $2500
    $4000

Our Clients